Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- F-1/A Registration statement (foreign)
- 10.4 Clinical Trial Research Agreement Between Alfred Health and Incannex Healthcare Limited, Dated June 22, 2021
- 10.5 Clinical Trial Research Agreement Between Alfred Health and Incannex Healthcare Limited, Dated September 24, 2020
- 10.6 Clinical Trial Research Agreement Between University of Western Australia and Incannex Healthcare Limited, Dated April 6, 2021
- 10.7 Master Consultancy Agreement Between Clinical Network Services (CNS) Pty LTD (Now Novotech Australia) Pty Limited) and Incannex Healthcare Limited, Dated June 29, 2020
- 10.8 Research Services Agreement Between Monash University and Incannex Healthcare Limited, Dated November 27, 2020
- 10.9 Research Services Agreement Between Monash University and Incannex Healthcare Limited, Dated March 10, 2021
- 10.10 Master Service Agreement Between Avance Clinical Pty Limited and Incannex Healthcare Limited, Dated July 12, 2021
- 10.11 Appendix No. 2 to the Master Consultancy Agreement Between Novotech Australia Pty Limited and Incannex Healthcare Limited, Dated February 2, 2021
- 23.1 Consent of Withum Smith+brown, PC
Associated filings
- 21 Jan 22 RW Registration withdrawal request
- 7 Dec 21 F-1/A Registration statement (foreign) (amended)
- 23 Nov 21 F-1/A Registration statement (foreign) (amended)
- 3 Nov 21 F-1/A Registration statement (foreign) (amended)
-
28 Sep 21 F-1/A Registration statement (foreign) (amended)
- 17 Aug 21 F-1 Registration statement (foreign)
IXHL similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement on Form F-1, Amendment No. 1, of our report dated 17 August 2021, which includes an explanatory paragraph relating to the Incannex Healthcare Limited’s (the “Company”) ability to continue as a going concern, relating to the consolidated financial statements of the Company, which is contained in that Prospectus. We also consent to the reference to us under the caption “Experts” in the Prospectus.
/s/ WithumSmith+Brown, PC
New York, New York
28 September 2021